Arvind Reddy Devanabanda

Arvind Reddy Devanabanda practices at Carle Health Methodist Hospital in Peoria, Illinois, part of The Carle Foundation.

Arvind Reddy Devanabanda's NPI, 1578974069, was assigned on May 19, 2014. Arvind Reddy Devanabanda graduated from Boston University School of Medicine in 2014. Arvind Reddy Devanabanda holds Illinois license 036158345.

Arvind Reddy Devanabanda's primary practice is Carle Health Methodist Hospital, at 221 N E Glen Oak Ave, Peoria, IL 61636 in Peoria County. The practice phone is (309) 672-5522.

Arvind Reddy Devanabanda's primary practice is Carle Health Methodist Hospital in Peoria, Illinois, part of The Carle Foundation. Arvind Reddy Devanabanda is also affiliated with OSF Saint Francis Medical Center. The medical group on file is Carle Physician Group. Dmand AI also links Arvind Reddy Devanabanda to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arvind Reddy Devanabanda practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Arvind Reddy Devanabanda's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Arvind Reddy Devanabanda's licenses on file in 2 states: Illinois and California.

CMS data shows 2,192 Medicare services from Arvind Reddy Devanabanda across 29 procedure codes in 2024, for 928 Medicare patients. Medicare paid $174,920 for them.

CMS counts 928 Medicare patients who saw Arvind Reddy Devanabanda in 2024. The largest group is 65 to 74, with 420 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Arvind Reddy Devanabanda's median patient age at 74, with 47% women.

In 2024, Arvind Reddy Devanabanda wrote 3,325 Medicare Part D claims for 500 patients. 84% of them were for generic drugs. CMS names the drug for 3,137 of them, across 32 drugs with 11 or more claims each, at $531,882 in total drug cost. In 2023, CMS named 2,429 claims across 32 drugs.

Arvind Reddy Devanabanda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 93 procedures of coronary angioplasty and stenting by Arvind Reddy Devanabanda, more than 96% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Arvind Reddy Devanabanda, published from 2016 to 2019. Arvind Reddy Devanabanda's most frequent co-authors are Sandipan Chakraborty, Raktim Kumar Ghosh, MD and Adrija Hajra.

CMS Open Payments shows 415 general payments to Arvind Reddy Devanabanda from 24 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 48% of the total. Abbott Laboratories paid the most, $15,599.

Arvind Reddy Devanabanda graduated from Boston University School of Medicine in 2014.